作者
Martin O Leach, KM Brindle, JL Evelhoch, John R Griffiths, Michael R Horsman, A Jackson, Gordon C Jayson, Ian R Judson, MV Knopp, Ross J Maxwell, D McIntyre, AR Padhani, P Price, R Rathbone, GJ Rustin, PS Tofts, GM Tozer, W Vennart, John C Waterton, SR Williams, Paul Workman
发表日期
2005/5
期刊
British journal of cancer
卷号
92
期号
9
页码范围
1599-1610
出版商
Nature Publishing Group
简介
Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor the action of these therapeutics in early-stage clinical trials. This publication reports the outcome of a workshop that considered the methodology and design of magnetic resonance studies, recommending how this new tool might best be used.
引用总数
200520062007200820092010201120122013201420152016201720182019202020212022202320246293948464647513341373528201617151585